nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Mesalazine—Crohn's disease	0.615	1	CrCtD
Droxidopa—Aminosalicylic Acid—Mesalazine—Crohn's disease	0.105	0.287	CrCrCtD
Droxidopa—Carbidopa—Mesalazine—Crohn's disease	0.0786	0.216	CrCrCtD
Droxidopa—Methyldopa—Mesalazine—Crohn's disease	0.0679	0.187	CrCrCtD
Droxidopa—Dopamine—Mesalazine—Crohn's disease	0.0679	0.187	CrCrCtD
Droxidopa—L-DOPA—Mesalazine—Crohn's disease	0.0451	0.124	CrCrCtD
Droxidopa—Aminosalicylic Acid—MPO—Crohn's disease	0.000414	0.222	CrCbGaD
Droxidopa—Mesalazine—MPO—Crohn's disease	0.000325	0.174	CrCbGaD
Droxidopa—Norepinephrine—SLC22A5—Crohn's disease	0.000248	0.133	CrCbGaD
Droxidopa—Dopamine—SLC22A5—Crohn's disease	0.000231	0.124	CrCbGaD
Droxidopa—Epinephrine—SLC22A5—Crohn's disease	0.000225	0.121	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—Crohn's disease	0.000155	0.0831	CrCbGaD
Droxidopa—Epinephrine—TNF—Crohn's disease	0.000148	0.079	CrCbGaD
Droxidopa—Mesalazine—PTGS2—Crohn's disease	0.000122	0.0652	CrCbGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	8.77e-06	0.000457	CbGpPWpGaD
Droxidopa—PAH—Disease—STAT3—Crohn's disease	8.75e-06	0.000456	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—RASGRP1—Crohn's disease	8.74e-06	0.000455	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	8.66e-06	0.000451	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	8.63e-06	0.00045	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—FADS1—Crohn's disease	8.52e-06	0.000444	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL3—Crohn's disease	8.44e-06	0.00044	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CXCL8—Crohn's disease	8.38e-06	0.000437	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IL2RA—Crohn's disease	8.37e-06	0.000436	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.35e-06	0.000435	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL3—Crohn's disease	8.31e-06	0.000433	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.22e-06	0.000429	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—RASGRP1—Crohn's disease	8.16e-06	0.000425	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	8.16e-06	0.000425	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	8.15e-06	0.000425	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	8.12e-06	0.000423	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.11e-06	0.000423	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	8.05e-06	0.000419	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—RASGRP1—Crohn's disease	8.03e-06	0.000419	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GPX4—Crohn's disease	7.98e-06	0.000416	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—ALB—Crohn's disease	7.97e-06	0.000415	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—JAK2—Crohn's disease	7.96e-06	0.000415	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SOCS1—Crohn's disease	7.95e-06	0.000414	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR6—Crohn's disease	7.88e-06	0.000411	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	7.86e-06	0.000409	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—IL2RA—Crohn's disease	7.72e-06	0.000402	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GCKR—Crohn's disease	7.71e-06	0.000402	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	7.63e-06	0.000398	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—TYK2—Crohn's disease	7.58e-06	0.000395	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	7.58e-06	0.000395	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CXCL8—Crohn's disease	7.57e-06	0.000394	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	7.55e-06	0.000393	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.54e-06	0.000393	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	7.47e-06	0.000389	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—ALB—Crohn's disease	7.45e-06	0.000388	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—JAK2—Crohn's disease	7.41e-06	0.000386	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	7.38e-06	0.000384	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	7.3e-06	0.00038	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CXCL8—Crohn's disease	7.27e-06	0.000379	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—JAK2—Crohn's disease	7.23e-06	0.000377	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR6—Crohn's disease	7.18e-06	0.000374	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	7.14e-06	0.000372	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RBX1—Crohn's disease	7.13e-06	0.000372	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR6—Crohn's disease	7.12e-06	0.000371	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	7.07e-06	0.000368	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	7.03e-06	0.000367	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR6—Crohn's disease	7.03e-06	0.000366	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL2RA—Crohn's disease	7.01e-06	0.000365	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—IL2RA—Crohn's disease	6.97e-06	0.000363	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	6.95e-06	0.000362	CbGpPWpGaD
Droxidopa—DDC—Metabolism—ALB—Crohn's disease	6.95e-06	0.000362	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	6.94e-06	0.000362	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.93e-06	0.000361	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—JAK2—Crohn's disease	6.92e-06	0.000361	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	6.88e-06	0.000359	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	6.87e-06	0.000358	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	6.85e-06	0.000357	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	6.65e-06	0.000346	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	6.63e-06	0.000345	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	6.6e-06	0.000344	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	6.54e-06	0.000341	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	6.51e-06	0.000339	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RBX1—Crohn's disease	6.5e-06	0.000339	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	6.44e-06	0.000335	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	6.41e-06	0.000334	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	6.39e-06	0.000333	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	6.36e-06	0.000331	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RBX1—Crohn's disease	6.35e-06	0.000331	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	6.33e-06	0.00033	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	6.32e-06	0.00033	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	6.27e-06	0.000327	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	6.25e-06	0.000326	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	6.25e-06	0.000326	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	6.19e-06	0.000322	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	6.18e-06	0.000322	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.15e-06	0.000321	CbGpPWpGaD
Droxidopa—PAH—Disease—IL6—Crohn's disease	6.11e-06	0.000319	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—Crohn's disease	6.08e-06	0.000317	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	6.06e-06	0.000316	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—ALB—Crohn's disease	6.05e-06	0.000315	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	6.01e-06	0.000313	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	5.92e-06	0.000308	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	5.91e-06	0.000308	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL3—Crohn's disease	5.91e-06	0.000308	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	5.85e-06	0.000305	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	5.82e-06	0.000303	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	5.81e-06	0.000303	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	5.76e-06	0.0003	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	5.74e-06	0.000299	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	5.72e-06	0.000298	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	5.7e-06	0.000297	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	5.69e-06	0.000297	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	5.64e-06	0.000294	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—JAK2—Crohn's disease	5.62e-06	0.000293	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	5.57e-06	0.00029	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	5.52e-06	0.000288	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	5.47e-06	0.000285	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	5.4e-06	0.000282	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	5.4e-06	0.000281	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL3—Crohn's disease	5.39e-06	0.000281	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL3—Crohn's disease	5.34e-06	0.000278	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	5.29e-06	0.000276	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	5.27e-06	0.000275	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL3—Crohn's disease	5.27e-06	0.000275	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	5.26e-06	0.000274	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	5.21e-06	0.000271	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	5.19e-06	0.00027	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	5.19e-06	0.00027	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	5.18e-06	0.00027	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	5.17e-06	0.000269	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	5.16e-06	0.000269	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	5.12e-06	0.000267	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	5.11e-06	0.000266	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	5.1e-06	0.000266	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	5.03e-06	0.000262	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL3—Crohn's disease	4.99e-06	0.00026	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	4.94e-06	0.000257	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL3—Crohn's disease	4.91e-06	0.000256	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	4.88e-06	0.000254	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	4.82e-06	0.000251	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	4.8e-06	0.00025	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	4.75e-06	0.000248	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	4.75e-06	0.000247	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	4.74e-06	0.000247	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	4.73e-06	0.000246	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	4.72e-06	0.000246	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	4.71e-06	0.000246	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	4.68e-06	0.000244	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	4.68e-06	0.000244	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	4.62e-06	0.000241	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	4.62e-06	0.000241	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	4.61e-06	0.00024	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	4.5e-06	0.000235	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TYK2—Crohn's disease	4.48e-06	0.000233	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	4.47e-06	0.000233	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	4.47e-06	0.000233	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	4.46e-06	0.000232	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	4.4e-06	0.000229	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	4.38e-06	0.000228	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	4.37e-06	0.000228	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL3—Crohn's disease	4.36e-06	0.000227	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	4.31e-06	0.000225	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	4.31e-06	0.000224	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	4.3e-06	0.000224	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	4.3e-06	0.000224	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	4.29e-06	0.000224	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	4.28e-06	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	4.28e-06	0.000223	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—JAK2—Crohn's disease	4.27e-06	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	4.25e-06	0.000222	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	4.22e-06	0.00022	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	4.22e-06	0.00022	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	4.2e-06	0.000219	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	4.17e-06	0.000217	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	4.15e-06	0.000216	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	4.14e-06	0.000216	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	4.1e-06	0.000214	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	4.07e-06	0.000212	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL3—Crohn's disease	4.05e-06	0.000211	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	4.04e-06	0.00021	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	3.99e-06	0.000208	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	3.99e-06	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	3.97e-06	0.000207	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	3.93e-06	0.000205	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	3.92e-06	0.000204	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	3.92e-06	0.000204	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	3.91e-06	0.000204	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	3.9e-06	0.000203	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	3.88e-06	0.000202	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	3.83e-06	0.0002	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	3.83e-06	0.000199	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	3.82e-06	0.000199	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	3.77e-06	0.000197	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	3.77e-06	0.000197	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	3.74e-06	0.000195	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	3.71e-06	0.000193	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—Crohn's disease	3.71e-06	0.000193	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	3.69e-06	0.000192	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	3.64e-06	0.00019	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	3.63e-06	0.000189	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	3.57e-06	0.000186	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	3.55e-06	0.000185	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	3.55e-06	0.000185	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	3.49e-06	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	3.49e-06	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	3.47e-06	0.000181	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	3.44e-06	0.000179	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	3.38e-06	0.000176	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	3.3e-06	0.000172	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.24e-06	0.000169	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	3.23e-06	0.000168	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	3.17e-06	0.000165	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—STAT3—Crohn's disease	3.14e-06	0.000163	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	3.06e-06	0.00016	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	3.05e-06	0.000159	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—Crohn's disease	3.02e-06	0.000157	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	2.95e-06	0.000153	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	2.92e-06	0.000152	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	2.84e-06	0.000148	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	2.78e-06	0.000145	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TYK2—Crohn's disease	2.66e-06	0.000139	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—Crohn's disease	2.64e-06	0.000138	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	2.63e-06	0.000137	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TYK2—Crohn's disease	2.6e-06	0.000136	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	2.54e-06	0.000132	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—JAK2—Crohn's disease	2.54e-06	0.000132	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	2.51e-06	0.000131	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—JAK2—Crohn's disease	2.48e-06	0.000129	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	2.46e-06	0.000128	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—Crohn's disease	2.45e-06	0.000128	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	2.42e-06	0.000126	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	2.42e-06	0.000126	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	2.35e-06	0.000122	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	2.31e-06	0.000121	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	2.31e-06	0.00012	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	2.29e-06	0.00012	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	2.26e-06	0.000118	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—Crohn's disease	2.2e-06	0.000115	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—Crohn's disease	2.19e-06	0.000114	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	2.18e-06	0.000114	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—Crohn's disease	2.15e-06	0.000112	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.15e-06	0.000112	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.15e-06	0.000112	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	2.14e-06	0.000112	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	2.11e-06	0.00011	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.05e-06	0.000107	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	2.04e-06	0.000106	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.04e-06	0.000106	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	2e-06	0.000104	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2e-06	0.000104	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	1.91e-06	9.94e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	1.87e-06	9.76e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—Crohn's disease	1.86e-06	9.7e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	1.84e-06	9.61e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—Crohn's disease	1.82e-06	9.49e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.78e-06	9.28e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	1.74e-06	9.07e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	1.72e-06	8.98e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	1.7e-06	8.84e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.65e-06	8.62e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.51e-06	7.85e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—Crohn's disease	1.43e-06	7.44e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.4e-06	7.29e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—Crohn's disease	1.3e-06	6.78e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—Crohn's disease	1.29e-06	6.71e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—Crohn's disease	1.27e-06	6.63e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.2e-06	6.27e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.18e-06	6.17e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.05e-06	5.48e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—Crohn's disease	9.77e-07	5.09e-05	CbGpPWpGaD
